Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance

Adam H. Buchanan, Santanu K. Datta, Celette Sugg Skinner, Gail P. Hollowell, Henry F. Beresford, Thomas Freeland, Benjamin Rogers, John Boling, P. Kelly Marcom, Martha B. Adams

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Telegenetics—genetic counseling via live videoconferencing—can improve access to cancer genetic counseling (CGC) in underserved areas, but studies on cancer telegenetics have not applied randomized methodology or assessed cost. We report cost, patient satisfaction and CGC attendance from a randomized trial comparing telegenetics with in-person CGC among individuals referred to CGC in four rural oncology clinics. Participants (n = 162) were randomized to receive CGC at their local oncology clinic in-person or via telegenetics. Cost analyses included telegenetics system; mileage; and personnel costs for genetic counselor, IT specialist, and clinic personnel. CGC attendance was tracked via study database. Patient satisfaction was assessed 1 week post-CGC via telephone survey using validated scales. Total costs were $106 per telegenetics patient and $244 per in-person patient. Patient satisfaction did not differ by group on either satisfaction scale. In-person patients were significantly more likely to attend CGC than telegenetics patients (89 vs. 79 %, p = 0.03), with bivariate analyses showing an association between lesser computer comfort and lower attendance rate (Chi-square = 5.49, p = 0.02). Our randomized trial of telegenetics vs. in-person counseling found that telegenetics cost less than in-person counseling, with high satisfaction among those who attended. This study provides support for future randomized trials comparing multiple service delivery models on longer-term psychosocial and behavioral outcomes.

Original languageEnglish (US)
Pages (from-to)961-970
Number of pages10
JournalJournal of Genetic Counseling
Volume24
Issue number6
DOIs
StatePublished - Dec 1 2015

Fingerprint

Genetic Counseling
Patient Satisfaction
Costs and Cost Analysis
Neoplasms
Counseling
Telephone
Databases

Keywords

  • Cancer genes
  • Cost analysis
  • Genetic counseling
  • Patient satisfaction
  • Telemedicine

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling : Cost, Patient Satisfaction and Attendance. / Buchanan, Adam H.; Datta, Santanu K.; Skinner, Celette Sugg; Hollowell, Gail P.; Beresford, Henry F.; Freeland, Thomas; Rogers, Benjamin; Boling, John; Marcom, P. Kelly; Adams, Martha B.

In: Journal of Genetic Counseling, Vol. 24, No. 6, 01.12.2015, p. 961-970.

Research output: Contribution to journalArticle

Buchanan, AH, Datta, SK, Skinner, CS, Hollowell, GP, Beresford, HF, Freeland, T, Rogers, B, Boling, J, Marcom, PK & Adams, MB 2015, 'Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance', Journal of Genetic Counseling, vol. 24, no. 6, pp. 961-970. https://doi.org/10.1007/s10897-015-9836-6
Buchanan, Adam H. ; Datta, Santanu K. ; Skinner, Celette Sugg ; Hollowell, Gail P. ; Beresford, Henry F. ; Freeland, Thomas ; Rogers, Benjamin ; Boling, John ; Marcom, P. Kelly ; Adams, Martha B. / Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling : Cost, Patient Satisfaction and Attendance. In: Journal of Genetic Counseling. 2015 ; Vol. 24, No. 6. pp. 961-970.
@article{2de8f37771b84b04aae05e15b200a0f7,
title = "Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance",
abstract = "Telegenetics—genetic counseling via live videoconferencing—can improve access to cancer genetic counseling (CGC) in underserved areas, but studies on cancer telegenetics have not applied randomized methodology or assessed cost. We report cost, patient satisfaction and CGC attendance from a randomized trial comparing telegenetics with in-person CGC among individuals referred to CGC in four rural oncology clinics. Participants (n = 162) were randomized to receive CGC at their local oncology clinic in-person or via telegenetics. Cost analyses included telegenetics system; mileage; and personnel costs for genetic counselor, IT specialist, and clinic personnel. CGC attendance was tracked via study database. Patient satisfaction was assessed 1 week post-CGC via telephone survey using validated scales. Total costs were $106 per telegenetics patient and $244 per in-person patient. Patient satisfaction did not differ by group on either satisfaction scale. In-person patients were significantly more likely to attend CGC than telegenetics patients (89 vs. 79 {\%}, p = 0.03), with bivariate analyses showing an association between lesser computer comfort and lower attendance rate (Chi-square = 5.49, p = 0.02). Our randomized trial of telegenetics vs. in-person counseling found that telegenetics cost less than in-person counseling, with high satisfaction among those who attended. This study provides support for future randomized trials comparing multiple service delivery models on longer-term psychosocial and behavioral outcomes.",
keywords = "Cancer genes, Cost analysis, Genetic counseling, Patient satisfaction, Telemedicine",
author = "Buchanan, {Adam H.} and Datta, {Santanu K.} and Skinner, {Celette Sugg} and Hollowell, {Gail P.} and Beresford, {Henry F.} and Thomas Freeland and Benjamin Rogers and John Boling and Marcom, {P. Kelly} and Adams, {Martha B.}",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s10897-015-9836-6",
language = "English (US)",
volume = "24",
pages = "961--970",
journal = "Journal of Genetic Counseling",
issn = "1059-7700",
publisher = "Kluwer Academic/Human Sciences Press Inc.",
number = "6",

}

TY - JOUR

T1 - Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling

T2 - Cost, Patient Satisfaction and Attendance

AU - Buchanan, Adam H.

AU - Datta, Santanu K.

AU - Skinner, Celette Sugg

AU - Hollowell, Gail P.

AU - Beresford, Henry F.

AU - Freeland, Thomas

AU - Rogers, Benjamin

AU - Boling, John

AU - Marcom, P. Kelly

AU - Adams, Martha B.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Telegenetics—genetic counseling via live videoconferencing—can improve access to cancer genetic counseling (CGC) in underserved areas, but studies on cancer telegenetics have not applied randomized methodology or assessed cost. We report cost, patient satisfaction and CGC attendance from a randomized trial comparing telegenetics with in-person CGC among individuals referred to CGC in four rural oncology clinics. Participants (n = 162) were randomized to receive CGC at their local oncology clinic in-person or via telegenetics. Cost analyses included telegenetics system; mileage; and personnel costs for genetic counselor, IT specialist, and clinic personnel. CGC attendance was tracked via study database. Patient satisfaction was assessed 1 week post-CGC via telephone survey using validated scales. Total costs were $106 per telegenetics patient and $244 per in-person patient. Patient satisfaction did not differ by group on either satisfaction scale. In-person patients were significantly more likely to attend CGC than telegenetics patients (89 vs. 79 %, p = 0.03), with bivariate analyses showing an association between lesser computer comfort and lower attendance rate (Chi-square = 5.49, p = 0.02). Our randomized trial of telegenetics vs. in-person counseling found that telegenetics cost less than in-person counseling, with high satisfaction among those who attended. This study provides support for future randomized trials comparing multiple service delivery models on longer-term psychosocial and behavioral outcomes.

AB - Telegenetics—genetic counseling via live videoconferencing—can improve access to cancer genetic counseling (CGC) in underserved areas, but studies on cancer telegenetics have not applied randomized methodology or assessed cost. We report cost, patient satisfaction and CGC attendance from a randomized trial comparing telegenetics with in-person CGC among individuals referred to CGC in four rural oncology clinics. Participants (n = 162) were randomized to receive CGC at their local oncology clinic in-person or via telegenetics. Cost analyses included telegenetics system; mileage; and personnel costs for genetic counselor, IT specialist, and clinic personnel. CGC attendance was tracked via study database. Patient satisfaction was assessed 1 week post-CGC via telephone survey using validated scales. Total costs were $106 per telegenetics patient and $244 per in-person patient. Patient satisfaction did not differ by group on either satisfaction scale. In-person patients were significantly more likely to attend CGC than telegenetics patients (89 vs. 79 %, p = 0.03), with bivariate analyses showing an association between lesser computer comfort and lower attendance rate (Chi-square = 5.49, p = 0.02). Our randomized trial of telegenetics vs. in-person counseling found that telegenetics cost less than in-person counseling, with high satisfaction among those who attended. This study provides support for future randomized trials comparing multiple service delivery models on longer-term psychosocial and behavioral outcomes.

KW - Cancer genes

KW - Cost analysis

KW - Genetic counseling

KW - Patient satisfaction

KW - Telemedicine

UR - http://www.scopus.com/inward/record.url?scp=84947029178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947029178&partnerID=8YFLogxK

U2 - 10.1007/s10897-015-9836-6

DO - 10.1007/s10897-015-9836-6

M3 - Article

C2 - 25833335

AN - SCOPUS:84947029178

VL - 24

SP - 961

EP - 970

JO - Journal of Genetic Counseling

JF - Journal of Genetic Counseling

SN - 1059-7700

IS - 6

ER -